Guest guest Posted July 6, 2011 Report Share Posted July 6, 2011 Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and Untreated Chronic Hepatitis C PatientsDigestive Diseases and Sciences Predicting response to therapy in chronic hepatitis C: an approach combining IL28B gene polymorphisms and clinical dataJournal of Gastroenterology and Hepatology High-Dose Pegylated Interferon-á and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B GenotypeGastroenterology Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.